Cost-effectiveness analysis of pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in the Chinese healthcare system - Lang, Wenwang; He, Yulong; Hou, Changchun; Li, Hua; Jiang, Qinling; Mei, Liuyong (Frontiers in Pharmacology, 2025)